个人中心 - 老虎社区

Toh_Chris

IP属地：未知

帖子 · 66帖子 · 66
关注 · 0关注 · 0
粉丝 · 0粉丝 · 0

- Toh_ChrisToh_Chris
  ·2021-10-15
  $LM Funding America(LMFA)$lucky
  666 评论
  1
  分享
  举报
- Toh_ChrisToh_Chris
  ·2021-10-05
  Willingness to move towards the future
  非常抱歉，此主贴已删除
  949 评论
  1
  分享
  举报
- Toh_ChrisToh_Chris
  ·2021-10-04
  Wonder why? Increase by $75.30!! Was it a mistake 😅😆
  920 评论
  点赞
  分享
  举报
- Toh_ChrisToh_Chris
  ·2021-10-01
  Something to consider
  1,021 评论
  点赞
  分享
  举报
- Toh_ChrisToh_Chris
  ·2021-10-01
  Another turn.
  Stocks rebound to start October on Merck’s promising oral Covid pill
  WASHINGTON(Reuters)-U.S. consumer spending increased more than expected in August, but a downward re
  Stocks rebound to start October on Merck’s promising oral Covid pill
  1,390 1
  6
  分享
  举报
- Toh_ChrisToh_Chris
  ·2021-10-01
  Great breakthrough!
  Moderna, BioNTech, Pfizer Fall on Merck Covid-19 Pill News
  By Geoffrey Smith Investing.com -- Shares in the makers of Covid-19 vaccines all fell sharply in pre
  Moderna, BioNTech, Pfizer Fall on Merck Covid-19 Pill News
  923 评论
  6
  分享
  举报
- Toh_ChrisToh_Chris
  ·2021-09-30
  Watchful
  非常抱歉，此主贴已删除
  1,270 评论
  5
  分享
  举报
- Toh_ChrisToh_Chris
  ·2021-09-29
  $Red Cat Holdings Inc.(RCAT)$Why?
  1,050 评论
  1
  分享
  举报
- Toh_ChrisToh_Chris
  ·2021-09-29
  $Red Cat Holdings Inc.(RCAT)$Oh! I thought it is going up😬
  1,058 评论
  点赞
  分享
  举报
- Toh_ChrisToh_Chris
  ·2021-09-28
  Great!
  Sonoma Pharmaceuticals shares surged 45% in premarket trading
  Sonoma Pharmaceuticals shares surged 45% in premarket trading after launching its first over-the-cou
  Sonoma Pharmaceuticals shares surged 45% in premarket trading
  860 评论
  5
  分享
  举报

热议股票

{"i18n":{"language":"zh_CN"},"isCurrentUser":false,"userPageInfo":{"id":"4092275556517550","uuid":"4092275556517550","gmtCreate":1629173646298,"gmtModify":1630030138393,"name":"Toh_Chris","pinyin":"tohchristohchris","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/59542e8b00ca7947839b37f753f1b0c2","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":9,"headSize":28,"tweetSize":66,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":3,"name":"书生虎","nameTw":"書生虎","represent":"努力向上","factor":"发布10条非转发主帖,其中5条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"35ec162348d5460f88c959321e554969-3","templateUuid":"35ec162348d5460f88c959321e554969","name":"传说交易员","description":"证券或期货账户累计交易次数达到300次","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.02.08","exceedPercentage":"93.40%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"228c86a078844d74991fff2b7ab2428d-2","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资总监虎","description":"证券账户累计交易金额达到30万美元","bigImgUrl":"https://static.tigerbbs.com/9d20b23f1b6335407f882bc5c2ad12c0","smallImgUrl":"https://static.tigerbbs.com/ada3b4533518ace8404a3f6dd192bd29","grayImgUrl":"https://static.tigerbbs.com/177f283ba21d1c077054dac07f88f3bd","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.01.21","exceedPercentage":"80.46%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":4,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":4,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":824691132,"gmtCreate":1634306747154,"gmtModify":1634306747383,"author":{"id":"4092275556517550","authorId":"4092275556517550","name":"Toh_Chris","avatar":"https://static.tigerbbs.com/59542e8b00ca7947839b37f753f1b0c2","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4092275556517550","idStr":"4092275556517550"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/LMFA\">$LM Funding America(LMFA)$</a>lucky","listText":"<a href=\"https://laohu8.com/S/LMFA\">$LM Funding America(LMFA)$</a>lucky","text":"$LM Funding America(LMFA)$lucky","images":[{"img":"https://static.tigerbbs.com/f9d7dba60cb9fda231b6250e2bcb5d74","width":"750","height":"1174"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/824691132","isVote":1,"tweetType":1,"viewCount":666,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":820737466,"gmtCreate":1633431370407,"gmtModify":1633432127496,"author":{"id":"4092275556517550","authorId":"4092275556517550","name":"Toh_Chris","avatar":"https://static.tigerbbs.com/59542e8b00ca7947839b37f753f1b0c2","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4092275556517550","idStr":"4092275556517550"},"themes":[],"htmlText":"Willingness to move towards the future&nbsp;","listText":"Willingness to move towards the future&nbsp;","text":"Willingness to move towards the future","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/820737466","repostId":"1133411996","repostType":4,"isVote":1,"tweetType":1,"viewCount":949,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":820945712,"gmtCreate":1633346918981,"gmtModify":1633346919199,"author":{"id":"4092275556517550","authorId":"4092275556517550","name":"Toh_Chris","avatar":"https://static.tigerbbs.com/59542e8b00ca7947839b37f753f1b0c2","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4092275556517550","idStr":"4092275556517550"},"themes":[],"htmlText":"Wonder why? Increase by $75.30!! Was it a mistake 😅😆","listText":"Wonder why? Increase by $75.30!! Was it a mistake 😅😆","text":"Wonder why? Increase by $75.30!! Was it a mistake 😅😆","images":[{"img":"https://static.tigerbbs.com/05cec00fa9d1c9f162e3e79bdb74b7d7","width":"750","height":"2201"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/820945712","isVote":1,"tweetType":1,"viewCount":920,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":864660319,"gmtCreate":1633097994269,"gmtModify":1633130254290,"author":{"id":"4092275556517550","authorId":"4092275556517550","name":"Toh_Chris","avatar":"https://static.tigerbbs.com/59542e8b00ca7947839b37f753f1b0c2","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4092275556517550","idStr":"4092275556517550"},"themes":[],"htmlText":"Something to consider&nbsp;","listText":"Something to consider&nbsp;","text":"Something to consider","images":[{"img":"https://static.tigerbbs.com/16fe2c6f0983c816203201c9e2466e34","width":"750","height":"2201"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/864660319","isVote":1,"tweetType":1,"viewCount":1021,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":864680840,"gmtCreate":1633097465080,"gmtModify":1633097465278,"author":{"id":"4092275556517550","authorId":"4092275556517550","name":"Toh_Chris","avatar":"https://static.tigerbbs.com/59542e8b00ca7947839b37f753f1b0c2","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4092275556517550","idStr":"4092275556517550"},"themes":[],"htmlText":"Another turn.","listText":"Another turn.","text":"Another turn.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/864680840","repostId":"1145898013","repostType":4,"repost":{"id":"1145898013","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1633095114,"share":"https://www.laohunote.com/m/news/1145898013?lang=&edition=full","pubTime":"2021-10-01 21:31","market":"us","language":"en","title":"Stocks rebound to start October on Merck’s promising oral Covid pill","url":"https://stock-news.laohu8.com/highlight/detail?id=1145898013","media":"Tiger Newspress","summary":"WASHINGTON(Reuters)-U.S. consumer spending increased more than expected in August, but a downward re","content":"<p>WASHINGTON(Reuters)-U.S. consumer spending increased more than expected in August, but a downward revision to July data kept intact expectations that economic growth slowed in the third quarter as a resurgence in COVID-19 infections curbed demand for services.</p>\n<p>Dow added 260 points, or 0.8%. The S&amp;P 500 and the Nasdaq Composite rose 0.5% and 0.2%, respectively.<img src=\"https://static.tigerbbs.com/0651731f7c9f3c7130af900f3a9a0f3a\" tg-width=\"1352\" tg-height=\"448\" referrerpolicy=\"no-referrer\">Shares of Dow member Merck<a href=\"https://laohu8.com/S/MRK\">$(MRK)$</a> jumped 8% after the drug maker and Ridgeback Biotherapeuticssaid their oral antiviral treatment for Covid-19reduced the risk of hospitalization or death by 50% for patients with mild or moderate cases. The companies plan to seek emergency authorization for the treatment.The Commerce Department said on Friday that consumer spending, which accounts for more than two-thirds of U.S. economic activity, rebounded 0.8% in August, shrugging off declining motor vehicle sales caused by a global shortage of semiconductors, which is undercutting the production of automobiles.</p>\n<p>The new drug from Merck appeared to boost travel stocks. Shares of Royal Caribbean and Las Vegas Sands added more than 1% in premarket trading. Southwest Airlines led a gain in airline stocks after JPMorganupgraded the stockand said most of the group was worth buying for a trade.</p>\n<p>The 10-year Treasury yield fell back below 1.50% in early trading. Futures on the tech-heavy Nasdaq went into the green as yields fell.</p>\n<p>The market just capped a tumultuous September as inflation fears, slowing growth and rising rates kept investors on edge. The S&amp;P 500 finished the month down 4.8%, breaking a seven-month winning streak. The Dow and the Nasdaq Composite fell 4.3% and 5.3%, respectively, suffering their worst months of the year.</p>\n<p>“A combination of slowing growth, less accommodative monetary policy, China headwinds, fading fiscal stimulus, and nagging supply chain bottlenecks all conspired to weigh on investor sentiment as we head into fall and 4Q21,” Chris Hussey, a managing director at Goldman Sachs, said in a note.</p>\n<p>Consumer spending grew at a robust 12.0% annualized rate in the second quarter, accounting for much of the economy's 6.7% growth pace, which raised the level of gross domestic product above its peak in the fourth quarter of 2019. Growth estimates for the third quarter are below a 5.0% rate.</p>\n<p>\"Consumer momentum should improve in the months ahead, driving the economy closer to a full post-pandemic recovery and keeping inflation hot,\" said David Kelly, chief global strategist at JPMorgan Funds in New York.</p>\n<p>Inflation maintained its upward trend in August. The personal consumption expenditures (PCE) price index, excluding the volatile food and energy components, climbed 0.3% after increasing by the same margin in July.</p>\n<p>In the 12 months through August, the so-called core PCE price index increased 3.6%, matching July's gain.</p>\n<p>The core PCE price index is the Federal Reserve's preferred inflation measure for its flexible 2% target. The Fed last week upgraded its core PCE inflation projection for this year to 3.7% from 3.0% back in June.</p>\n<p>The U.S. central bank said it would likely begin reducing its monthly bond purchases as soon as November and signaled interest rate increases may follow more quickly than expected.</p>\n<p>Fed Chair Jerome Powell told lawmakers on Thursday that he anticipated some relief from high inflation in the months ahead.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stocks rebound to start October on Merck’s promising oral Covid pill</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStocks rebound to start October on Merck’s promising oral Covid pill\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-10-01 21:31</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>WASHINGTON(Reuters)-U.S. consumer spending increased more than expected in August, but a downward revision to July data kept intact expectations that economic growth slowed in the third quarter as a resurgence in COVID-19 infections curbed demand for services.</p>\n<p>Dow added 260 points, or 0.8%. The S&amp;P 500 and the Nasdaq Composite rose 0.5% and 0.2%, respectively.<img src=\"https://static.tigerbbs.com/0651731f7c9f3c7130af900f3a9a0f3a\" tg-width=\"1352\" tg-height=\"448\" referrerpolicy=\"no-referrer\">Shares of Dow member Merck<a href=\"https://laohu8.com/S/MRK\">$(MRK)$</a> jumped 8% after the drug maker and Ridgeback Biotherapeuticssaid their oral antiviral treatment for Covid-19reduced the risk of hospitalization or death by 50% for patients with mild or moderate cases. The companies plan to seek emergency authorization for the treatment.The Commerce Department said on Friday that consumer spending, which accounts for more than two-thirds of U.S. economic activity, rebounded 0.8% in August, shrugging off declining motor vehicle sales caused by a global shortage of semiconductors, which is undercutting the production of automobiles.</p>\n<p>The new drug from Merck appeared to boost travel stocks. Shares of Royal Caribbean and Las Vegas Sands added more than 1% in premarket trading. Southwest Airlines led a gain in airline stocks after JPMorganupgraded the stockand said most of the group was worth buying for a trade.</p>\n<p>The 10-year Treasury yield fell back below 1.50% in early trading. Futures on the tech-heavy Nasdaq went into the green as yields fell.</p>\n<p>The market just capped a tumultuous September as inflation fears, slowing growth and rising rates kept investors on edge. The S&amp;P 500 finished the month down 4.8%, breaking a seven-month winning streak. The Dow and the Nasdaq Composite fell 4.3% and 5.3%, respectively, suffering their worst months of the year.</p>\n<p>“A combination of slowing growth, less accommodative monetary policy, China headwinds, fading fiscal stimulus, and nagging supply chain bottlenecks all conspired to weigh on investor sentiment as we head into fall and 4Q21,” Chris Hussey, a managing director at Goldman Sachs, said in a note.</p>\n<p>Consumer spending grew at a robust 12.0% annualized rate in the second quarter, accounting for much of the economy's 6.7% growth pace, which raised the level of gross domestic product above its peak in the fourth quarter of 2019. Growth estimates for the third quarter are below a 5.0% rate.</p>\n<p>\"Consumer momentum should improve in the months ahead, driving the economy closer to a full post-pandemic recovery and keeping inflation hot,\" said David Kelly, chief global strategist at JPMorgan Funds in New York.</p>\n<p>Inflation maintained its upward trend in August. The personal consumption expenditures (PCE) price index, excluding the volatile food and energy components, climbed 0.3% after increasing by the same margin in July.</p>\n<p>In the 12 months through August, the so-called core PCE price index increased 3.6%, matching July's gain.</p>\n<p>The core PCE price index is the Federal Reserve's preferred inflation measure for its flexible 2% target. The Fed last week upgraded its core PCE inflation projection for this year to 3.7% from 3.0% back in June.</p>\n<p>The U.S. central bank said it would likely begin reducing its monthly bond purchases as soon as November and signaled interest rate increases may follow more quickly than expected.</p>\n<p>Fed Chair Jerome Powell told lawmakers on Thursday that he anticipated some relief from high inflation in the months ahead.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1145898013","content_text":"WASHINGTON(Reuters)-U.S. consumer spending increased more than expected in August, but a downward revision to July data kept intact expectations that economic growth slowed in the third quarter as a resurgence in COVID-19 infections curbed demand for services.\nDow added 260 points, or 0.8%. The S&P 500 and the Nasdaq Composite rose 0.5% and 0.2%, respectively.Shares of Dow member Merck$(MRK)$ jumped 8% after the drug maker and Ridgeback Biotherapeuticssaid their oral antiviral treatment for Covid-19reduced the risk of hospitalization or death by 50% for patients with mild or moderate cases. The companies plan to seek emergency authorization for the treatment.The Commerce Department said on Friday that consumer spending, which accounts for more than two-thirds of U.S. economic activity, rebounded 0.8% in August, shrugging off declining motor vehicle sales caused by a global shortage of semiconductors, which is undercutting the production of automobiles.\nThe new drug from Merck appeared to boost travel stocks. Shares of Royal Caribbean and Las Vegas Sands added more than 1% in premarket trading. Southwest Airlines led a gain in airline stocks after JPMorganupgraded the stockand said most of the group was worth buying for a trade.\nThe 10-year Treasury yield fell back below 1.50% in early trading. Futures on the tech-heavy Nasdaq went into the green as yields fell.\nThe market just capped a tumultuous September as inflation fears, slowing growth and rising rates kept investors on edge. The S&P 500 finished the month down 4.8%, breaking a seven-month winning streak. The Dow and the Nasdaq Composite fell 4.3% and 5.3%, respectively, suffering their worst months of the year.\n“A combination of slowing growth, less accommodative monetary policy, China headwinds, fading fiscal stimulus, and nagging supply chain bottlenecks all conspired to weigh on investor sentiment as we head into fall and 4Q21,” Chris Hussey, a managing director at Goldman Sachs, said in a note.\nConsumer spending grew at a robust 12.0% annualized rate in the second quarter, accounting for much of the economy's 6.7% growth pace, which raised the level of gross domestic product above its peak in the fourth quarter of 2019. Growth estimates for the third quarter are below a 5.0% rate.\n\"Consumer momentum should improve in the months ahead, driving the economy closer to a full post-pandemic recovery and keeping inflation hot,\" said David Kelly, chief global strategist at JPMorgan Funds in New York.\nInflation maintained its upward trend in August. The personal consumption expenditures (PCE) price index, excluding the volatile food and energy components, climbed 0.3% after increasing by the same margin in July.\nIn the 12 months through August, the so-called core PCE price index increased 3.6%, matching July's gain.\nThe core PCE price index is the Federal Reserve's preferred inflation measure for its flexible 2% target. The Fed last week upgraded its core PCE inflation projection for this year to 3.7% from 3.0% back in June.\nThe U.S. central bank said it would likely begin reducing its monthly bond purchases as soon as November and signaled interest rate increases may follow more quickly than expected.\nFed Chair Jerome Powell told lawmakers on Thursday that he anticipated some relief from high inflation in the months ahead.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1390,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":864616200,"gmtCreate":1633097236095,"gmtModify":1633097318428,"author":{"id":"4092275556517550","authorId":"4092275556517550","name":"Toh_Chris","avatar":"https://static.tigerbbs.com/59542e8b00ca7947839b37f753f1b0c2","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4092275556517550","idStr":"4092275556517550"},"themes":[],"htmlText":"Great breakthrough!","listText":"Great breakthrough!","text":"Great breakthrough!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/864616200","repostId":"2172968435","repostType":4,"repost":{"id":"2172968435","kind":"news","pubTimestamp":1633097043,"share":"https://www.laohunote.com/m/news/2172968435?lang=&edition=full","pubTime":"2021-10-01 22:04","market":"us","language":"en","title":"Moderna, BioNTech, Pfizer Fall on Merck Covid-19 Pill News","url":"https://stock-news.laohu8.com/highlight/detail?id=2172968435","media":"Investing.com","summary":"By Geoffrey Smith\nInvesting.com -- Shares in the makers of Covid-19 vaccines all fell sharply in pre","content":"<p>By Geoffrey Smith</p>\n<p>Investing.com -- Shares in the makers of Covid-19 vaccines all fell sharply in premarket trading on Friday on expectations that Merck's experimental pill for treating the disease could radically undercut future demand for their drugs.</p>\n<p>By (8:45 AM ET 1345 GMT), Moderna (NASDAQ:MRNA) stock was down 4.9%, while BioNTech stock was down 5.3% and Pfizer (NYSE:PFE) stock was down 1.9%.&nbsp; Pfizer has traditionally been the least price-sensitive to vaccine news because it has many other revenue sources, whereas the other two are, for the present at least, pure plays on Covid-19 treatments.</p>\n<p>Merck (NYSE:MRK) had said earlier that an early-stage trial of its experimental pill had led to clear reductions in hospitalizations among the sample group, all of whom had taken it after developing moderate symptoms of Covid-19.</p>\n<p>The study was stopped early, as is often the case when an experimental drug shows signs of efficacy.</p>\n<p>Scientists have searched feverishly for a Covid-19 remedy that can be manufactured, distributed and administered at massive scale without arousing the suspicions and mistrust that often accompany new vaccines. Such a pill could transform the vaccination status of many poorer countries, where Covid-19 is still spreading more or less unimpeded due to the lack of vaccines in the developing world.</p>\n<p>Related Articles</p>\n<p>Moderna, BioNTech, Pfizer Fall on Merck Covid-19 Pill News</p>\n<p>Stocks under pressure as euro zone inflation hits 13-year high</p>\n<p>Merck's COVID-19 pill cuts risk of death, hospitalization by 50% in study</p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna, BioNTech, Pfizer Fall on Merck Covid-19 Pill News</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna, BioNTech, Pfizer Fall on Merck Covid-19 Pill News\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-01 22:04 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/moderna-biontech-pfizer-fall-merck-085413419.html><strong>Investing.com</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>By Geoffrey Smith\nInvesting.com -- Shares in the makers of Covid-19 vaccines all fell sharply in premarket trading on Friday on expectations that Merck's experimental pill for treating the disease ...</p>\n\n<a href=\"https://finance.yahoo.com/news/moderna-biontech-pfizer-fall-merck-085413419.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRK":"默沙东","MRNA":"Moderna, Inc.","PFE":"辉瑞","NWS":"新闻集团"},"source_url":"https://finance.yahoo.com/news/moderna-biontech-pfizer-fall-merck-085413419.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2172968435","content_text":"By Geoffrey Smith\nInvesting.com -- Shares in the makers of Covid-19 vaccines all fell sharply in premarket trading on Friday on expectations that Merck's experimental pill for treating the disease could radically undercut future demand for their drugs.\nBy (8:45 AM ET 1345 GMT), Moderna (NASDAQ:MRNA) stock was down 4.9%, while BioNTech stock was down 5.3% and Pfizer (NYSE:PFE) stock was down 1.9%.  Pfizer has traditionally been the least price-sensitive to vaccine news because it has many other revenue sources, whereas the other two are, for the present at least, pure plays on Covid-19 treatments.\nMerck (NYSE:MRK) had said earlier that an early-stage trial of its experimental pill had led to clear reductions in hospitalizations among the sample group, all of whom had taken it after developing moderate symptoms of Covid-19.\nThe study was stopped early, as is often the case when an experimental drug shows signs of efficacy.\nScientists have searched feverishly for a Covid-19 remedy that can be manufactured, distributed and administered at massive scale without arousing the suspicions and mistrust that often accompany new vaccines. Such a pill could transform the vaccination status of many poorer countries, where Covid-19 is still spreading more or less unimpeded due to the lack of vaccines in the developing world.\nRelated Articles\nModerna, BioNTech, Pfizer Fall on Merck Covid-19 Pill News\nStocks under pressure as euro zone inflation hits 13-year high\nMerck's COVID-19 pill cuts risk of death, hospitalization by 50% in study","news_type":1},"isVote":1,"tweetType":1,"viewCount":923,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":865661848,"gmtCreate":1632976715427,"gmtModify":1632976715641,"author":{"id":"4092275556517550","authorId":"4092275556517550","name":"Toh_Chris","avatar":"https://static.tigerbbs.com/59542e8b00ca7947839b37f753f1b0c2","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4092275556517550","idStr":"4092275556517550"},"themes":[],"htmlText":"Watchful&nbsp;","listText":"Watchful&nbsp;","text":"Watchful","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/865661848","repostId":"1104172212","repostType":4,"isVote":1,"tweetType":1,"viewCount":1270,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":865042991,"gmtCreate":1632926518068,"gmtModify":1632926518309,"author":{"id":"4092275556517550","authorId":"4092275556517550","name":"Toh_Chris","avatar":"https://static.tigerbbs.com/59542e8b00ca7947839b37f753f1b0c2","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4092275556517550","idStr":"4092275556517550"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/RCAT\">$Red Cat Holdings Inc.(RCAT)$</a>Why?","listText":"<a href=\"https://laohu8.com/S/RCAT\">$Red Cat Holdings Inc.(RCAT)$</a>Why?","text":"$Red Cat Holdings Inc.(RCAT)$Why?","images":[{"img":"https://static.tigerbbs.com/c099945e824070ad62eb16c117983c94","width":"750","height":"1068"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/865042991","isVote":1,"tweetType":1,"viewCount":1050,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":862155173,"gmtCreate":1632847556425,"gmtModify":1632847556534,"author":{"id":"4092275556517550","authorId":"4092275556517550","name":"Toh_Chris","avatar":"https://static.tigerbbs.com/59542e8b00ca7947839b37f753f1b0c2","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4092275556517550","idStr":"4092275556517550"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/RCAT\">$Red Cat Holdings Inc.(RCAT)$</a>Oh! I thought it is going up😬","listText":"<a href=\"https://laohu8.com/S/RCAT\">$Red Cat Holdings Inc.(RCAT)$</a>Oh! I thought it is going up😬","text":"$Red Cat Holdings Inc.(RCAT)$Oh! I thought it is going up😬","images":[{"img":"https://static.tigerbbs.com/cdb0894fff3b3e2c3723a3f1c2f61b99","width":"750","height":"1068"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/862155173","isVote":1,"tweetType":1,"viewCount":1058,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":862989414,"gmtCreate":1632829085061,"gmtModify":1632829085132,"author":{"id":"4092275556517550","authorId":"4092275556517550","name":"Toh_Chris","avatar":"https://static.tigerbbs.com/59542e8b00ca7947839b37f753f1b0c2","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4092275556517550","idStr":"4092275556517550"},"themes":[],"htmlText":"Great!","listText":"Great!","text":"Great!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/862989414","repostId":"1126986798","repostType":4,"repost":{"id":"1126986798","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1632827257,"share":"https://www.laohunote.com/m/news/1126986798?lang=&edition=full","pubTime":"2021-09-28 19:07","market":"us","language":"en","title":"Sonoma Pharmaceuticals shares surged 45% in premarket trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1126986798","media":"Tiger Newspress","summary":"Sonoma Pharmaceuticals shares surged 45% in premarket trading after launching its first over-the-cou","content":"<p>Sonoma Pharmaceuticals shares surged 45% in premarket trading&nbsp;after&nbsp;launching its first over-the-counter products in the U.S. on amazon and a new consumer-focused product on amazon in Europe.</p>\n<p><img src=\"https://static.tigerbbs.com/1b36dd566a7aa3d834858c9e28652591\" tg-width=\"850\" tg-height=\"619\" referrerpolicy=\"no-referrer\"></p>\n<p>Sonoma Pharmaceuticals, Inc. , a global healthcare leader developing and producing stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, eye care, nasal care, oral care, and dermatological conditions, today announced the over-the-counter (“OTC”) consumer launch of Regenacyn®Advanced Scar Gel and Ocucyn®Eyelid &amp; Eyelash Cleanser on Amazon.com, and MucoClyns™ on Amazon sites in Europe. All three products are based on Sonoma’s patented Microcyn®technology and are immediately available for customer orders.</p>\n<p>Sonoma&nbsp;offers its superior, safe and effective hypochlorous acid products directly to consumers. For years, Sonoma has offered its products as prescription or office dispense products available only from physicians. The OTC launch creates an additional line of Sonoma products marketed directly to consumers and provides a direct channel that makes its proven Microcyn®technology widely available for all.</p>\n<p>Regenacyn Advanced Scar Gel is clinically proven to improve the overall appearance of scars while reducing pain, itch, redness and inflammation. Regenacyn Advanced Scar Gel protects and moisturizes wound and scar sites to promote lighter, flatter and less prominent scarring. Regenacyn Advanced Scar Gel is non-toxic, non-irritating and non-sensitizing.</p>\n<p>Ocucyn Eyelid &amp; Eyelash Cleanser, designed for everyday use, is a safe, gentle &amp; effective solution for good eyelid &amp; eyelash hygiene. Ocucyn Eyelid &amp; Eyelash Cleanser helps clean dirty and crusty irritated eyelids. Ocucyn Eyelid &amp; Eyelash Cleanser is steroid free, non-irritating, non-cytotoxic, non-sensitizing and requires no special handling.</p>\n<p>MucoClyns is a personal decontamination solution for the face and skin. MucoClyns is safe to use on mucous membranes, cuts, abrasions, burns and body surfaces to clean and treat immediately after unexpected exposure to infection risk. MucoClyns is biocompatible for its indicated use and safe and non-irritating to human skin.</p>\n<p><b>About Sonoma Pharmaceuticals, Inc.</b></p>\n<p>Sonoma Pharmaceuticals is a global healthcare leader for developing and producing stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, animal health care, eye care, nasal care, oral care, disinfectant use and dermatological conditions. The company’s products reduce infections, itch, pain, scarring and harmful inflammatory responses in a safe and effective manner. In-vitro and clinical studies of hypochlorous acid (HOCl) show it to have impressive antipruritic, antimicrobial, antiviral and anti-inflammatory properties. Sonoma’s stabilized HOCl immediately relieves itch and pain, kills pathogens and breaks down biofilm, does not sting or irritate skin and oxygenates the cells in the area treated assisting the body in its natural healing process. The company’s products are sold either directly or via partners in 54 countries worldwide and the company actively seeks new distribution partners. The company’s principal office is in Woodstock, Georgia, with manufacturing operations in Latin America. European marketing and sales are headquartered in Roermond, Netherlands.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Sonoma Pharmaceuticals shares surged 45% in premarket trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSonoma Pharmaceuticals shares surged 45% in premarket trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-09-28 19:07</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Sonoma Pharmaceuticals shares surged 45% in premarket trading&nbsp;after&nbsp;launching its first over-the-counter products in the U.S. on amazon and a new consumer-focused product on amazon in Europe.</p>\n<p><img src=\"https://static.tigerbbs.com/1b36dd566a7aa3d834858c9e28652591\" tg-width=\"850\" tg-height=\"619\" referrerpolicy=\"no-referrer\"></p>\n<p>Sonoma Pharmaceuticals, Inc. , a global healthcare leader developing and producing stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, eye care, nasal care, oral care, and dermatological conditions, today announced the over-the-counter (“OTC”) consumer launch of Regenacyn®Advanced Scar Gel and Ocucyn®Eyelid &amp; Eyelash Cleanser on Amazon.com, and MucoClyns™ on Amazon sites in Europe. All three products are based on Sonoma’s patented Microcyn®technology and are immediately available for customer orders.</p>\n<p>Sonoma&nbsp;offers its superior, safe and effective hypochlorous acid products directly to consumers. For years, Sonoma has offered its products as prescription or office dispense products available only from physicians. The OTC launch creates an additional line of Sonoma products marketed directly to consumers and provides a direct channel that makes its proven Microcyn®technology widely available for all.</p>\n<p>Regenacyn Advanced Scar Gel is clinically proven to improve the overall appearance of scars while reducing pain, itch, redness and inflammation. Regenacyn Advanced Scar Gel protects and moisturizes wound and scar sites to promote lighter, flatter and less prominent scarring. Regenacyn Advanced Scar Gel is non-toxic, non-irritating and non-sensitizing.</p>\n<p>Ocucyn Eyelid &amp; Eyelash Cleanser, designed for everyday use, is a safe, gentle &amp; effective solution for good eyelid &amp; eyelash hygiene. Ocucyn Eyelid &amp; Eyelash Cleanser helps clean dirty and crusty irritated eyelids. Ocucyn Eyelid &amp; Eyelash Cleanser is steroid free, non-irritating, non-cytotoxic, non-sensitizing and requires no special handling.</p>\n<p>MucoClyns is a personal decontamination solution for the face and skin. MucoClyns is safe to use on mucous membranes, cuts, abrasions, burns and body surfaces to clean and treat immediately after unexpected exposure to infection risk. MucoClyns is biocompatible for its indicated use and safe and non-irritating to human skin.</p>\n<p><b>About Sonoma Pharmaceuticals, Inc.</b></p>\n<p>Sonoma Pharmaceuticals is a global healthcare leader for developing and producing stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, animal health care, eye care, nasal care, oral care, disinfectant use and dermatological conditions. The company’s products reduce infections, itch, pain, scarring and harmful inflammatory responses in a safe and effective manner. In-vitro and clinical studies of hypochlorous acid (HOCl) show it to have impressive antipruritic, antimicrobial, antiviral and anti-inflammatory properties. Sonoma’s stabilized HOCl immediately relieves itch and pain, kills pathogens and breaks down biofilm, does not sting or irritate skin and oxygenates the cells in the area treated assisting the body in its natural healing process. The company’s products are sold either directly or via partners in 54 countries worldwide and the company actively seeks new distribution partners. The company’s principal office is in Woodstock, Georgia, with manufacturing operations in Latin America. European marketing and sales are headquartered in Roermond, Netherlands.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1126986798","content_text":"Sonoma Pharmaceuticals shares surged 45% in premarket trading after launching its first over-the-counter products in the U.S. on amazon and a new consumer-focused product on amazon in Europe.\n\nSonoma Pharmaceuticals, Inc. , a global healthcare leader developing and producing stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, eye care, nasal care, oral care, and dermatological conditions, today announced the over-the-counter (“OTC”) consumer launch of Regenacyn®Advanced Scar Gel and Ocucyn®Eyelid & Eyelash Cleanser on Amazon.com, and MucoClyns™ on Amazon sites in Europe. All three products are based on Sonoma’s patented Microcyn®technology and are immediately available for customer orders.\nSonoma offers its superior, safe and effective hypochlorous acid products directly to consumers. For years, Sonoma has offered its products as prescription or office dispense products available only from physicians. The OTC launch creates an additional line of Sonoma products marketed directly to consumers and provides a direct channel that makes its proven Microcyn®technology widely available for all.\nRegenacyn Advanced Scar Gel is clinically proven to improve the overall appearance of scars while reducing pain, itch, redness and inflammation. Regenacyn Advanced Scar Gel protects and moisturizes wound and scar sites to promote lighter, flatter and less prominent scarring. Regenacyn Advanced Scar Gel is non-toxic, non-irritating and non-sensitizing.\nOcucyn Eyelid & Eyelash Cleanser, designed for everyday use, is a safe, gentle & effective solution for good eyelid & eyelash hygiene. Ocucyn Eyelid & Eyelash Cleanser helps clean dirty and crusty irritated eyelids. Ocucyn Eyelid & Eyelash Cleanser is steroid free, non-irritating, non-cytotoxic, non-sensitizing and requires no special handling.\nMucoClyns is a personal decontamination solution for the face and skin. MucoClyns is safe to use on mucous membranes, cuts, abrasions, burns and body surfaces to clean and treat immediately after unexpected exposure to infection risk. MucoClyns is biocompatible for its indicated use and safe and non-irritating to human skin.\nAbout Sonoma Pharmaceuticals, Inc.\nSonoma Pharmaceuticals is a global healthcare leader for developing and producing stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, animal health care, eye care, nasal care, oral care, disinfectant use and dermatological conditions. The company’s products reduce infections, itch, pain, scarring and harmful inflammatory responses in a safe and effective manner. In-vitro and clinical studies of hypochlorous acid (HOCl) show it to have impressive antipruritic, antimicrobial, antiviral and anti-inflammatory properties. Sonoma’s stabilized HOCl immediately relieves itch and pain, kills pathogens and breaks down biofilm, does not sting or irritate skin and oxygenates the cells in the area treated assisting the body in its natural healing process. The company’s products are sold either directly or via partners in 54 countries worldwide and the company actively seeks new distribution partners. The company’s principal office is in Woodstock, Georgia, with manufacturing operations in Latin America. European marketing and sales are headquartered in Roermond, Netherlands.","news_type":1},"isVote":1,"tweetType":1,"viewCount":860,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"defaultTab":"posts","isTTM":false}